Taste and Smell Impairment in Critically Ill COVID-19 Patients
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT04532632
Recruitment Status :
First Posted : August 31, 2020
Last Update Posted : November 10, 2020
Pinar Ay Sayin
Information provided by (Responsible Party):
Pinar Ay Sayin, Sisli Hamidiye Etfal Training and Research Hospital
Patients who were treated in the intensive care unit of Şişli Hamidiye Etfal Training and Research Hospital with the diagnosis of Coronavirus disease-19 will be determined by scanning the hospital registry system. It was planned that patients discharged from the intensive care unit would be called by phone and their complaints about smell and taste disorders were evaluated with a questionnaire.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
18 Years to 80 Years (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Patients between the ages of 18-80, who were treated in the intensive care unit with the diagnosis of Coronavirus disease-19 and were discharged
Adults between the ages of 18-80
Agree to participate in the study
Patients treated in the intensive care unit with the diagnosis of Coronavirus disease-19
Pre-existing smell and taste impairment
The patients have no enough cooperation to answer the questionnaire
Having additional diseases such as dementia and Alzheimer